TrakCel logo — Transforming Cellular Orchestration for Cell & Gene Therapy....

TrakCel

Transforming Cellular Orchestration for Cell & Gene Therapy. Join us. See the journey.

Founded 2012 United Kingdom United Kingdom 96 employees Corporate Round Supply Chain

General Information

Company Name TrakCel
Founded Year 2012
Location United Kingdom United Kingdom +2
Employees 96
Industries Supply Chain
Funding Stage Corporate Round
Social

Get notified when TrakCel moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About TrakCel

TrakCel is a United Kingdom based startup that specializes in transforming cellular orchestration for cell and gene therapy. The company's flagship platform, OCELLOS, manages and tracks all components of the cell and gene therapy supply chain, ensuring safe and efficient delivery of therapies to patients at both clinical and commercial stages. Founded in 2012, TrakCel's solutions cover the entire advanced therapy patient journey, providing comprehensive chain of custody, chain of identity, and traceability. The recent corporate round investment in 03 March 2021 saw participation from LabCorp and Cencora. TrakCel's innovative approach and focus on uniting and transforming the future of therapy supply chains position it as a key player in the supply chain industry. The company's commitment to driving efficiency and safety in the delivery of advanced therapies makes it a compelling prospect for potential investors.

Taxonomy: Cell Therapy, Gene Therapy, Regenerative Therapy Logistics, Risk Mitigation, Chain of Custody, Chain of Identity, Technology Platform, Patient Journey, Data Orchestration, Therapy Supply Chain, Regenerative Therapy, Data Integration

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round •••••• 2
Investor
•••• ••••
03 Mar 2021
Venture Round •••••• 2
Investor
•••• ••••
19 Oct 2016

TrakCel Alternatives & Competitors

TrakCel vs
Vineti
Vineti United States

Vineti’s Personalized Therapy Management (PTM®) drives and scales advanced therapies

Series C
20 employees
Biotechnology, Computing
TrakCel vs
ImmunoScape
ImmunoScape Singapore

Transforming Cancer Therapy with Our Novel Seed-and-Boost Approach

Unknown
23 employees
Biotechnology, Life Sciences
TrakCel vs

RMG is an innovative group of multifaceted clinicians aiming to provide well-rounded and effective c...

47 employees
Health Care, Health and Wellness

FAQ About TrakCel

Transforming Cellular Orchestration for Cell & Gene Therapy. Join us. See the journey.
TrakCel was founded in 2012.
TrakCel is headquartered in United Kingdom.
TrakCel operates in the following industries: Supply Chain.
TrakCel has approximately 96 employees.
TrakCel has completed 2 funding rounds. The latest funding stage is Corporate Round.
Top alternatives and competitors to TrakCel include Vineti, ImmunoScape, Regenerative Medical Group, CGT Global, American Society of Gene & Cell Therapy. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TrakCel and Vineti are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors TrakCel and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy